Literature DB >> 6982334

Clinical characteristics and course in patients with high titer anti-RNP antibodies.

J P Lemmer, N H Curry, J H Mallory, M V Waller.   

Abstract

Forty-four patients with high titers of anti-RNP antibodies, without anti-Sm or anti-nDNA antibodies, were studied retrospectively for clinical symptomatology, morbidity and mortality. Seven had died. Eleven had renal disease. Of patients with disease course greater than 7 years, only half had features of overlapping connective tissue diseases. The finding of high titer anti-RNP antibodies without anti-Sm or anti-nDNA did not appear to imply a distinct or unique clinical diagnosis or prognosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982334

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

Review 1.  Current management of polymyositis and dermatomyositis.

Authors:  C V Oddis; T A Medsger
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

2.  Mixed connective tissue disease. A clinico-serological study of 17 cases.

Authors:  I García-de la Torre; M Salazar-Páramo; G Salmón-de la Torre
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

3.  Overlap connective tissue syndromes.

Authors:  R C Allen; C St-Cyr; P J Maddison; B M Ansell
Journal:  Arch Dis Child       Date:  1986-03       Impact factor: 3.791

4.  Polymyositis associated with several immunological disorders.

Authors:  A H Vilppula; R A Aine
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

5.  HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease.

Authors:  E Genth; H Zarnowski; R Mierau; D Wohltmann; P W Hartl
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

6.  Antigen specificity of antihistone antibodies in connective tissue disease patients with anti-U1RNP antibodies.

Authors:  Takamasa Wayaku; Minoru Hasegawa; Kenzo Kaji; Miki Kondo; Yuki Saito; Hidemitsu Orito; Mayuka Horikawa; Takashi Matsushita; Kazuhiro Komura; Ikuko Hayakawa; Yasuhito Hamaguchi; Fumihide Ogawa; Manabu Fujimoto; Kazuhiko Takehara; Shinichi Sato
Journal:  Rheumatol Int       Date:  2007-07-13       Impact factor: 2.631

7.  Is MCTD a distinct entity? Comparison of clinical and laboratory findings in MCTD, SLE, PSS, and RA patients.

Authors:  L S De Clerck; K A Meijers; A Cats
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

8.  Follow-up of 151 patients with high-titer U1RNP antibodies.

Authors:  P B Frandsen; N J Kriegbaum; S Ullman; M Høier-Madsen; A Wiik; P Halberg
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.